Copay help by condition · Mental health and substance use · read 2026-11-08
Schizophrenia: which charitable copay funds are open
1 fund for Schizophrenia says it is open right now, of the 2 we hold (read 2026-11-08).
Open: Schizophrenia - Medicare Access from HealthWell Foundation. Eligibility is each fund's own rule.
If you have Medicare Part D: CMS prints the annual out-of-pocket threshold as $2,400 in 2027 ($2,100 in 2026) (Table V-2 of its CY 2027 announcement). It is a benefit parameter and applies to covered drugs under plan rules. What changes on January 1.
Swipe to read across
A copy for a patient, a clinic or a pharmacist, with each source and the date we read it.
Every fund we hold for Schizophrenia
- OpenSchizophrenia - Medicare Access
HealthWell Foundation ·
Award level: not statedInsurance supported: not stated
The page lists the fund as Open. Source page
- Closed or at capacitySchizophrenia
TotalAssist (Patient Advocate Foundation copay funds) ·
Award level: $4,200Insurance supported: Medicaid, Medicare, TRICARE
The page lists the fund as Closed. Source page
Drugs whose FDA label names Schizophrenia
8 drugs. Each row quotes the sentence of the drug's FDA label (Indications and Usage, openFDA) that names the condition. A label naming a condition is not a statement that the drug is approved, effective or covered for you. Dashes in quotes are shown as hyphens. Of these, 6 have a program (in our assistance finder or on the program's own page) and 1 has a Medicare negotiated price in the CMS file; an empty cell says we found nothing in our data, not that nothing exists.
| Drug | What the FDA label says | Manufacturer program | Medicare negotiated price |
|---|---|---|---|
| Rexulti Brexpiprazole Every route for this drug | Adjunctive treatment to antidepressants for major depressive disorder (MDD) in adults Treatment of schizophrenia in adults and pediatric patients ages 13 years and older Treatment of agitation associated with dementia due to Alzheimer's ... Label on openFDA, read 2026-11-10 | Mental Health Medication Assistance (Multiple Programs) | selected by CMS for 2028; price not yet published |
| Vraylar Cariprazine Every route for this drug | Treatment of schizophrenia in adult and pediatric patients 13 years of age and older [see Clinical Studies ( 14. Label on openFDA, read 2026-11-10 | Mental Health Medication Assistance (Multiple Programs) myAbbVie Assist | $770.00 for a 30-day supply, effective 2027-01-01 |
| Aristada Aripiprazole Lauroxil Every route for this drug | ARISTADA is indicated for the treatment of schizophrenia in adults [see Clinical Studies ( 14 )]. Label on openFDA, read 2026-11-10 | ARISTADA Patient Assistance Program (program page) | not in the CMS negotiated-price file |
| Caplyta Lumateperone Tosylate Every route for this drug | Treatment of schizophrenia in adults [see Clinical Studies (14. Label on openFDA, read 2026-11-10 | Johnson & Johnson Patient Assistance Program | not in the CMS negotiated-price file |
| Invega Sustenna, Invega Trinza, Invega Hafyera Paliperidone Palmitate Every route for this drug | Schizophrenia in adults [see Clinical Studies (14. Label on openFDA, read 2026-11-10 | J&J Patient Assistance Foundation (JJPAF) | not in the CMS negotiated-price file |
| Risperdal Consta Risperidone Microspheres Every route for this drug | Treatment of schizophrenia ( 1. Label on openFDA, read 2026-11-10 | Johnson & Johnson Patient Assistance Program | not in the CMS negotiated-price file |
| Abilify Maintena Aripiprazole | Schizophrenia • Irritability Associated with Autistic Disorder • Treatment of Tourette’s Disorder Aripiprazole is an atypical antipsychotic. Label on openFDA, read 2026-11-10 | not in our assistance finder | not in the CMS negotiated-price file |
| Lurasidone Hcl | Treatment of adult and adolescent patients (13 to 17 years) with schizophrenia [see Clinical Studies (14. Label on openFDA, read 2026-11-10 | not in our assistance finder | not in the CMS negotiated-price file |
Related conditions
No broader or more specific condition page for this one.
Group: Mental health and substance use. All conditions: the condition index. Fund board for every condition: charitable copay fund status.
What changed
First read on 2026-11-08. We keep each read with its date, so a fund reopening or closing will show here as a change. Until we have a second read there is nothing to compare, and we do not guess. The read date of every source is on the changes page.
This page as data
The same facts as JSON, each fund with its source URL and read date: schizophrenia.json. Edition 2026-11, root 006ab9a329709cbe. See the licence page.
Questions
Is there an open charitable copay fund for Schizophrenia?
As read on 2026-11-08, 1 of the 2 funds we hold for Schizophrenia say they are open: Schizophrenia - Medicare Access from HealthWell Foundation. Funds open and close, so check the source page before you apply.
Which organizations run funds for Schizophrenia?
HealthWell Foundation and TotalAssist (Patient Advocate Foundation copay funds). Each fund row on this page links to the organization's own page.
Does an open fund mean I qualify?
No. A status says whether a fund is taking applications. Eligibility, award level and which insurance it supports are each fund's own rules; where the page states them they are shown on the fund.
How current is this page?
Statuses are what each fund's own page said on the date we read it (2026-11-08). We do not promise a fund is still in that state today.